EQUITY ALERT: The Rosen Law Firm Announces Investigation of Receptos, Inc. Concerning its Proposed Sale to Celgene Corporation
18 Luglio 2015 - 12:52AM
Business Wire
The Rosen Law Firm, a global investor rights law firm, announces
that it is investigating the Board of Directors of Receptos, Inc.
(NASDAQ: RCPT) for possible breaches of fiduciary duty and other
violations of law by failing to adequately shop Receptos to
maximize shareholder value before agreeing to be acquired by
Celgene Corporation (NASDAQ: CELG).
If you would like to join the action, go to the firm’s website
at http://rosenlegal.com/cases-669.html or contact Phillip Kim or
Kevin Chan toll-free at 866-767-3653 or via e-mail at
pkim@rosenlegal.com or kchan@rosenlegal.com. There is no cost or
obligation to you.
Under the terms of the proposed transaction, shareholders will
receive $232.00 in cash for each share of Receptos stock they own.
The proposed transaction is valued at approximately $7.2 billion.
The investigation relates to whether the proposal is fair to the
public shareholders of Receptos and whether Receptos’ Board
breached its fiduciary duties in connection with the proposed
sale.
If you currently own shares of Receptos, Inc. and wish to obtain
additional information, please visit the firm’s website at
http://rosenlegal.com/cases-669.html. You may also contact Phillip
Kim or Kevin Chan of The Rosen Law Firm toll free at 866-767-3653
or via e-mail at pkim@rosenlegal.com or kchan@rosenlegal.com.
The Rosen Law Firm represents investors throughout the globe,
concentrating its practice in securities class actions and
shareholder derivative litigation.
Attorney Advertising. Prior results do not guarantee a similar
outcome.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150717005827/en/
The Rosen Law Firm, P.A.Phillip Kim, Esq.Kevin Chan,
Esq.Laurence Rosen, Esq.275 Madison Avenue, 34th FloorNew York, NY
10016Tel: (212) 686-1060Toll Free: 1-866-767-3653Fax: (212)
202-3827pkim@rosenlegal.comkchan@rosenlegal.comlrosen@rosenlegal.comwww.rosenlegal.com
Grafico Azioni RECEPTOS, INC. (NASDAQ:RCPT)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni RECEPTOS, INC. (NASDAQ:RCPT)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a (MM) (NASDAQ): 0 articoli recenti
Più Receptos, Inc. (MM) Articoli Notizie